Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Naïve Patients with Advanced HIV-1 Infection in the HAART Era

Post–Renal Transplant Cytomegalovirus Infection: Study of Risk Factors

(2012) V.B. Kute et al.   TRANSPLANTATION PROCEEDINGS

Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa

(2011) Katherine Fielding et al.   PLoS One

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

(2009)   AIDS

Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030

(2009) D. A. Wohl et al.   HIV CLINICAL TRIALS

Prevalence, Risk Factors, and Impact on Outcome of Cytomegalovirus Replication in Serum of Cambodian HIV-Infected Patients (2004-2007)

(2009) Romain Micol et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

(2009)   LANCET

Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy

(2009) Andre C. Kalil et al.   PLoS One